Creative Planning’s Day One Biopharmaceuticals DAWN Stock Holding History

Creative Planning’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,931	Closed	-$685K	–	4334
2026 Q1	$685K	Buy	31,931 +6,638	+26%	+$93.5K	﹤0.01%	2775
2025 Q4	$236K	Sell	25,293 -903	-3%	-$7.54K	﹤0.01%	3423
2025 Q3	$185K	Buy	26,196 +7,689	+42%	+$52.9K	﹤0.01%	3520
2025 Q2	$120K	Buy	+18,507	New	+$127K	﹤0.01%	3387

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Creative Planning's DAWN Position: Q2 2026 in Review

Creative Planning sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 31,931 shares — an estimated $685K sold.

Creative Planning first reported a position in DAWN in Q2 2025 and held it in 4 quarters. The position peaked at $685K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Creative Planning reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Creative Planning sold 31,931 Day One Biopharmaceuticals shares in Q2 2026, an estimated $685K.
Creative Planning first reported a position in Day One Biopharmaceuticals in Q2 2025 and held it in 4 quarters.
Creative Planning's Day One Biopharmaceuticals position peaked at $685K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.